7.3 OSHA Bloodborne Pathogens Standard and Workplace Safety

7.3 OSHA Bloodborne Pathogens Standard and Workplace Safety

Quick Summary: The Occupational Safety and Health Administration (OSHA) regulates clinical safety to prevent occupational transmission of infectious diseases. Under the Bloodborne Pathogens Standard (29 CFR 1910.1030), employers must maintain an annually updated Exposure Control Plan (ECP), enforce Standard Precautions, provide Engineering Controls (safety needles, biohazard containers) and Work Practice Controls (no needle recapping, hand hygiene), offer free Hepatitis B vaccination within 10 working days of assignment, and execute strict Post-Exposure Prophylaxis (PEP) protocols following exposure incidents.

---

OSHA and the Bloodborne Pathogens Standard

Established under the Occupational Safety and Health Act of 1970, OSHA is a federal agency within the U.S. Department of Labor tasked with assuring safe and healthful working conditions. In 1991, OSHA promulgated the landmark Bloodborne Pathogens Standard (29 CFR 1910.1030) to protect healthcare workers from exposure to dangerous bloodborne pathogens, most notably Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV).

The Exposure Control Plan (ECP)

Every healthcare facility where occupational exposure to blood or other potentially infectious materials (OPIM) can occur must maintain a written Exposure Control Plan (ECP).

• Mandatory Review: The ECP must be reviewed and updated at least annually and whenever new tasks, procedures, or employee positions are established that affect occupational exposure.
• Employee Involvement: Under federal amendments, employers must solicit input from non-managerial clinical staff (including MAs and phlebotomists) who are responsible for direct patient care regarding the identification, evaluation, and selection of effective engineering and work practice controls.
• Accessibility: The ECP must be readily accessible to all employees at all times during work shifts.

---

Universal Precautions vs. Standard Precautions

Understanding the evolution of infection control precautions is essential for national medical assistant certification exams.

                  Evolution of Infection Control Standards
                                     │
        ┌────────────────────────────┴────────────────────────────┐
        ▼                                                         ▼
 Universal Precautions (CDC 1985)                        Standard Precautions (CDC 1996/2007)
 • Focus: Blood & specified fluids                       • Focus: Blood, ALL body fluids,
   (semen, vaginal secretions, CSF).                       secretions, excretions (EXCEPT sweat),
 • Triggered by known pathogen risk.                       non-intact skin, mucous membranes.
                                                         • Applied universally to ALL patients.

---

Engineering Controls vs. Work Practice Controls

OSHA mandates a hierarchy of hazard controls to minimize employee exposures. Engineering controls are prioritized first, followed by work practice controls and Personal Protective Equipment (PPE).

The Needlestick Safety and Prevention Act (2000)

Congress passed the Needlestick Safety and Prevention Act to revise the OSHA Bloodborne Pathogens Standard, establishing specific mandates:

1. Employers must evaluate and implement appropriate safer medical devices (e.g., needleless systems, shielded venipuncture devices).
2. Employers must maintain an accurate, confidential Sharps Injury Log documenting:
   • The type and brand of device involved in the exposure incident.
   • The department or work area where the exposure occurred.
   • An explanation of how the incident occurred.

---

Personal Protective Equipment (PPE) Guidelines

Personal Protective Equipment acts as a barrier between the healthcare worker and potential pathogens. Employers must provide appropriate PPE at no cost to employees.

• Gloves: Must be worn whenever anticipating contact with blood, OPIM, mucous membranes, or non-intact skin. Must be replaced immediately if torn or contaminated.
• Gowns / Lab Coats: Worn during procedures likely to generate splashes or sprays of blood or body fluids.
• Face Shields / Masks & Goggles: Must be worn during procedures (e.g., arterial blood draws, wound irrigation, instrument debridement) that pose a risk of eye, nose, or mouth splashes.

---

Mandatory Hepatitis B Vaccination Offer

Hepatitis B is a major occupational hazard for clinical healthcare personnel due to its durability on environmental surfaces and high transmission efficiency via percutaneous injury.

                    Employee Assigned to Position with Occupational Exposure
                                                │
                           Within 10 Working Days of Assignment
                                                │
                  ┌─────────────────────────────┴─────────────────────────────┐
                  ▼                                                           ▼
     Employee Accepts Offer                                      Employee Declines Offer
     • Vaccine series provided FREE                              • Must sign mandatory OSHA
     • Provided at reasonable time/place                           Declination Statement
     • Post-vaccination titer testing                            • May request vaccine later at
       1-2 months post-series                                      NO COST while still exposed

• Timeline & Cost: Employers must offer the complete Hepatitis B vaccine series free of charge to all employees with occupational exposure risk within 10 working days of initial job assignment.
• Declination Form: If an employee refuses the vaccine, they must sign the official OSHA Mandatory Hepatitis B Vaccine Declination Statement. However, if the employee changes their mind at a later date, the employer must still provide the vaccine series free of charge.
• Titer Verification: Post-vaccination serologic testing (anti-HBs titer) should be performed 1 to 2 months after completion of the vaccine series to confirm immunity.

---

Post-Exposure Prophylaxis (PEP) Protocol

An exposure incident is defined as a specific eye, mouth, other mucous membrane, non-intact skin, or parenteral contact with blood or OPIM resulting from the performance of an employee's duties.

                         OCCUPATIONAL EXPOSURE INCIDENT
                                       │
                                       ▼
                    STEP 1: Immediate Decontamination / First Aid
                    • Wash skin / puncture with soap & water
                    • Flush mucous membranes / eyes with saline or water
                                       │
                                       ▼
                    STEP 2: Immediate Incident Reporting
                    • Report immediately to supervisor & Exposure Officer
                                       │
                                       ▼
                    STEP 3: Medical Evaluation & Baseline Blood Testing
                    • Obtain consent & test exposed employee (HIV, HBV, HCV)
                    • Test source patient (if consent granted / legally authorized)
                                       │
                                       ▼
                    STEP 4: Post-Exposure Prophylaxis (PEP)
                    • HIV PEP: Initiate combination ART ideally within 2 hours
                      (up to 72 hours maximum)
                    • HBV PEP: Administer HBIG + Vaccine if non-immune
                                       │
                                       ▼
                    STEP 5: Counseling & Follow-up Testing
                    • Follow-up serology at 6 weeks, 12 weeks, and 6 months

Immediate Post-Exposure Action Steps

1. Immediate First Aid: Wash needle sticks and cuts thoroughly with soap and water. Flush splashes to nose, mouth, or skin with water. Irrigate eyes with clean water, saline, or sterile wash for at least 15 minutes.
2. Report Incident Immediately: Notify the clinical supervisor and Safety/Exposure Officer to initiate formal reporting protocols.
3. Medical Evaluation: Conduct confidential medical evaluation. Obtain baseline serologic testing for HIV, HBV, and HCV from the employee and source patient (subject to consent regulations).
4. PEP Regimen Timelines:
   • HIV PEP: Antiretroviral therapy (ART) should be initiated as soon as possible, ideally within 2 hours and no later than 72 hours post-exposure, continuing for 28 days.
   • HBV PEP: If the employee is unvaccinated or a non-responder, Hepatitis B Immune Globulin (HBIG) and the HBV vaccine series must be initiated promptly.